Last update 29 May 2024

KYV-101

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
KYV 101, KYV-101, KYV101
Target
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), T lymphocyte replacements
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationFast Track (US), Orphan Drug (US)

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Scleroderma, DiffusePhase 2-01 May 2024
Multiple Sclerosis, Chronic ProgressivePhase 2-01 Apr 2024
Multiple Sclerosis, Primary ProgressivePhase 2-01 Apr 2024
Multiple Sclerosis, Secondary ProgressivePhase 2-01 Apr 2024
Myasthenia GravisPhase 2-01 Mar 2024
Lupus NephritisPhase 2
DE
01 Dec 2022
Scleroderma, SystemicPhase 2
US
-
Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisPhase 1-01 Jun 2024
Idiopathic Inflammatory MyopathiesPhase 1-01 Jun 2024
DermatomyositisPhase 1
US
01 Apr 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
1
ywnrsfivap(tsxpcdvdbq) = dobgedvatz gjthsjvjla (hsgocgwanl )
Positive
15 Nov 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free